Sign Out
KEMOPLAT 1 mg/ml is indicated for following indications: Metastatic Testicular Cancer: In established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors who have already received appropriate surgical and/or radio therapeutic procedures.
Metastatic Ovarian Cancer: In established combination therapy with other approved chemotherapeutic agents.
KEMOPLAT 1 mg/ml is used in patients with metastatic ovarian tumors who have already received appropriate surgical and/or radio therapeutic procedures. Also as a single agent, it is indicated as secondary therapy in patients with metastatic ovarian tumors refractory to standard chemotherapy who have not previously received cisplatin therapy.
Advanced Bladder Cancer: Cisplatin is indicated as a single agent for patients with transitional cell bladder cancer, which is no longer amenable to local treatments such as surgery and/or radiotherapy.
